FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018307266> ?p ?o ?g. }

• W2018307266 endingPage "124" @default.
• W2018307266 startingPage "119" @default.
• W2018307266 abstract "We examined the prevalence of various cutaneous symptoms including livedo racemosa and inflammatory plaques, lupus anticoagulant (LA), anticardiolipin (aCL) antibodies (Abs), and anti-phosphatidylserine-prothrombin complex (anti-PS/PT) Abs in patients with cutaneous polyarteritis nodosa (PAN) to determine if any of them correlate with the clinical and/or serologic features. If such correlations exist, the clinical and serologic features of the cutaneous manifestations could aid in the early diagnosis and/or treatment of cutaneous PAN. We retrospectively investigated the clinical and serologic features, direct immunofluorescence findings, and treatment methods used in 50 patients with cutaneous PAN seen at our Department of Dermatology between 2003 and 2009. Subcutaneous nodules were observed in all 50 patients, 44 (88.0%) had livedo racemosa, 30 (60.0%) had skin ulcers, and 14 (28.0%) had inflammatory plaques. Levels of serum IgM anti-PS/PT Abs were significantly higher in patients with livedo racemosa than in patients without livedo racemosa. Serum IgG anti-PS/PT Ab levels differed significantly between patients with inflammatory plaques (12.86 ± 13.16 U/mL) and those without inflammatory plaques (6.53 ± 5.92 U/mL). Similar trends were seen with respect to IgG aCL Ab levels. In contrast, levels of IgM anti-PS/PT Abs were significantly lower in patients with inflammatory plaques compared to patients without them. Inflammatory plaques were significantly more prevalent in patients with skin ulcers. Warfarin and prednisolone were selected as the primary therapy at a significantly higher rate in patients with inflammatory plaques and skin ulcers than in patients without them. We suggest that a variety of antiphospholipid Abs could influence the cutaneous patterns of cutaneous PAN. In particular, IgG anti-PS/PT Abs and/or IgG aCL Abs could indicate the presence of inflammatory plaques as a specific cutaneous manifestation of cutaneous PAN. Abbreviations: Abs = antibodies, aCL = anticardiolipin, ANCA=antineutrophil cytoplasmic autoantibody, anti-PS/PT = anti-phosphatidylserine-prothrombin complex, aPL = antiphospholipid, CI = confidence interval, DIF = direct immunofluorescence, LA = lupus anticoagulant, MPO = myeloperoxidase, OR = odds ratio, PAN = polyarteritis nodosa, PR3 = proteinase 3, SLE = systemic lupus erythematosus" @default.
• W2018307266 created "2016-06-24" @default.
• W2018307266 creator A5000774882 @default.
• W2018307266 creator A5033451411 @default.
• W2018307266 date "2011-03-01" @default.
• W2018307266 modified "2023-10-13" @default.
• W2018307266 title "Correlation of Livedo Racemosa, Cutaneous Inflammatory Plaques, and Antiphospholipid Antibodies in Patients With Cutaneous Polyarteritis Nodosa" @default.
• W2018307266 cites W1978914694 @default.
• W2018307266 cites W1991721757 @default.
• W2018307266 cites W1994178269 @default.
• W2018307266 cites W2001903607 @default.
• W2018307266 cites W2020294005 @default.
• W2018307266 cites W2028776205 @default.
• W2018307266 cites W2044390641 @default.
• W2018307266 cites W2054330426 @default.
• W2018307266 cites W2062700528 @default.
• W2018307266 cites W2068418903 @default.
• W2018307266 cites W2069794594 @default.
• W2018307266 cites W2070527591 @default.
• W2018307266 cites W2071944256 @default.
• W2018307266 cites W2074953444 @default.
• W2018307266 cites W2075445217 @default.
• W2018307266 cites W2160272430 @default.
• W2018307266 cites W2168896328 @default.
• W2018307266 cites W3021852519 @default.
• W2018307266 cites W4244494468 @default.
• W2018307266 doi "https://doi.org/10.1097/md.0b013e3182115508" @default.
• W2018307266 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21358438" @default.
• W2018307266 hasPublicationYear "2011" @default.
• W2018307266 type Work @default.
• W2018307266 sameAs 2018307266 @default.
• W2018307266 citedByCount "18" @default.
• W2018307266 countsByYear W20183072662012 @default.
• W2018307266 countsByYear W20183072662013 @default.
• W2018307266 countsByYear W20183072662015 @default.
• W2018307266 countsByYear W20183072662016 @default.
• W2018307266 countsByYear W20183072662017 @default.
• W2018307266 countsByYear W20183072662019 @default.
• W2018307266 countsByYear W20183072662020 @default.
• W2018307266 countsByYear W20183072662021 @default.
• W2018307266 countsByYear W20183072662022 @default.
• W2018307266 countsByYear W20183072662023 @default.
• W2018307266 crossrefType "journal-article" @default.
• W2018307266 hasAuthorship W2018307266A5000774882 @default.
• W2018307266 hasAuthorship W2018307266A5033451411 @default.
• W2018307266 hasConcept C126322002 @default.
• W2018307266 hasConcept C142724271 @default.
• W2018307266 hasConcept C159654299 @default.
• W2018307266 hasConcept C16005928 @default.
• W2018307266 hasConcept C203014093 @default.
• W2018307266 hasConcept C2776015282 @default.
• W2018307266 hasConcept C2776527422 @default.
• W2018307266 hasConcept C2776715498 @default.
• W2018307266 hasConcept C2779134260 @default.
• W2018307266 hasConcept C2779974317 @default.
• W2018307266 hasConcept C2780022809 @default.
• W2018307266 hasConcept C2780868729 @default.
• W2018307266 hasConcept C45189115 @default.
• W2018307266 hasConcept C71924100 @default.
• W2018307266 hasConcept C90924648 @default.
• W2018307266 hasConceptScore W2018307266C126322002 @default.
• W2018307266 hasConceptScore W2018307266C142724271 @default.
• W2018307266 hasConceptScore W2018307266C159654299 @default.
• W2018307266 hasConceptScore W2018307266C16005928 @default.
• W2018307266 hasConceptScore W2018307266C203014093 @default.
• W2018307266 hasConceptScore W2018307266C2776015282 @default.
• W2018307266 hasConceptScore W2018307266C2776527422 @default.
• W2018307266 hasConceptScore W2018307266C2776715498 @default.
• W2018307266 hasConceptScore W2018307266C2779134260 @default.
• W2018307266 hasConceptScore W2018307266C2779974317 @default.
• W2018307266 hasConceptScore W2018307266C2780022809 @default.
• W2018307266 hasConceptScore W2018307266C2780868729 @default.
• W2018307266 hasConceptScore W2018307266C45189115 @default.
• W2018307266 hasConceptScore W2018307266C71924100 @default.
• W2018307266 hasConceptScore W2018307266C90924648 @default.
• W2018307266 hasIssue "2" @default.
• W2018307266 hasLocation W20183072661 @default.
• W2018307266 hasOpenAccess W2018307266 @default.
• W2018307266 hasPrimaryLocation W20183072661 @default.
• W2018307266 hasRelatedWork W1997390220 @default.
• W2018307266 hasRelatedWork W2100693449 @default.
• W2018307266 hasRelatedWork W2195253067 @default.
• W2018307266 hasRelatedWork W2337181313 @default.
• W2018307266 hasRelatedWork W2337794968 @default.
• W2018307266 hasRelatedWork W2415639599 @default.
• W2018307266 hasRelatedWork W2426625160 @default.
• W2018307266 hasRelatedWork W2440917772 @default.
• W2018307266 hasRelatedWork W2471268552 @default.
• W2018307266 hasRelatedWork W68948154 @default.
• W2018307266 hasVolume "90" @default.
• W2018307266 isParatext "false" @default.
• W2018307266 isRetracted "false" @default.
• W2018307266 magId "2018307266" @default.
• W2018307266 workType "article" @default.